NUBURU A (ASE) stock price
NYSEAMERICAN:BURU · NYSE Amex · Machinery · sector #12NUBURU A (ASE)'s chart data is dated 2026-10-29. Recorded technical signals: MACD bullish cross. The display ticker is BURU.
NUBURU A (ASE) last closed at $0.3717 (+115.98%) on 2026-10-29. Signals today: MACD bullish cross. Listed on NYSE Amex. Trailing 12 months PER is -0.0×. Its overall grade ranks 143 of 157 stocks in Machinery.
About this company
Nuburu had approximately 220 granted and pending patents and patent applications globally in 2024. Nuburu focused on developing and delivering high-power, high-brightness blue laser technology in 2024. Nuburu adopted a new business plan in January 2025.
Quantus's relationship data lists competitors: IPG Photonics, Coherent, TRUMPF and 3 more; customers: Raytheon Technologies, Lockheed Martin, Northrop Grumman and 2 more.
By revenue it ranks No. 153 of the 153 companies with revenue data in Machinery, with less than 0.1% of the sector's total revenue.
The sector is fragmented: its top three companies hold 22.2% of revenue.
Source: 10-K FY2025 · SEC, business description (filed 2026-03-31)
Reported results
Position in sector
Machinery · Overall F · 143/157
Valuation grade A+
Related stocks
- Raytheon TechnologiesCustomer
- Lockheed MartinCustomer
- Northrop GrummanCustomer
About NUBURU A (ASE)
- What technical signals does NUBURU A (ASE) (BURU) have?
- NUBURU A (ASE) current technical signals: MACD bullish cross.
- What published figures are available for NUBURU A (ASE)?
- Market cap: $33.24M. Trailing 12 months PER: -0.0×. Latest quarter PBR: 0.03×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-30 dataset
Turn what you saw on this name into a strategy
Ask Q about NUBURU A (ASE), or open the plan table on the main site.
Ask Q about NUBURU A (ASE).
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.